SCHEMBL5312883

SCHEMBL5312883

O=C(/C=C/c1ccccc1)OCc1ccccc1O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.67
AKR1B10 O60218 7/20 0.61
AKR1B1 P15121 7/20 0.61
CA12 O43570 3/20 0.61
CA7 P43166 3/20 0.61
CA9 Q16790 3/20 0.61
CA14 Q9ULX7 3/20 0.61
CA4 P22748 2/20 0.61
CA6 P23280 2/20 0.61
CA5A P35218 2/20 0.61
CA5B Q9Y2D0 2/20 0.61
TTR P02766 1/20 0.56
MAOB P27338 1/20 0.54
RAB9A P51151 2/20 0.53
APP P05067 1/20 0.53
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
ESR1 P03372 1/20 0.50
ESR2 Q92731 1/20 0.50
BCHE P06276 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5312885 1.00 LMNA (0.67) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL78103 0.87 HCAR2 (0.53) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL2340792 0.87 HCAR2 (0.53) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL21678780 0.84 HCAR2 (0.65) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL78104 0.84 HCAR2 (0.65) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL17800130 0.83 LMNA (0.65) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL5176891 0.81 IDO1 (0.46) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL11716927 0.81 LMNA (0.61) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL11716934 0.81 LMNA (0.61) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL13833759 0.80 LMNA (0.93) LMNAAKR1B10AKR1B1CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1803809-A2 Modulation of peroxisome proliferator-activated receptors Abgenomics Corporation (TW) 2007-07-04 EP claimed
US-20070037193-A1 Modulation of peroxisome proliferator-activated receptors ABGENOMICS CORPORATION (TW) 2007-02-15 US claimed
EP-1803809-A2 Modulation of peroxisome proliferator-activated receptors Abgenomics Corporation (TW) 2007-07-04 EP disclosed
US-20070037193-A1 Modulation of peroxisome proliferator-activated receptors ABGENOMICS CORPORATION (TW) 2007-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070037193-A1 Modulation of peroxisome proliferator-activated receptors PPARG, PPARA, PPARD LMNA 2640/4885AKR1B10 75/4885AKR1B1 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.